GABA-a channel subunit expression in human glioma correlates with tumor histology and clinical outcome

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Smits, Anja ^a   Jin, Zhe ^a   Elsir, Tamador ^a,b   Pedder, Hugo ^a   Nistér, Monica ^b   Alafuzoff, Irina ^a   Dimberg, Anna ^a   Edqvist, Per Henrik ^a   Pontén, Fredrik ^a   Aronica, Eleonora ^c,d   Birnir, Bryndis ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA1; 4 AMINOBUTYRIC ACID A RECEPTOR GAMMA1; 4 AMINOBUTYRIC ACID A RECEPTOR RHO2; 4 AMINOBUTYRIC ACID A RECEPTOR THETA; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER PROGNOSIS; CANCER SURVIVAL; CELLULAR DISTRIBUTION; FEMALE; GLIOBLASTOMA; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OLIGODENDROGLIOMA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE MICROARRAY;

ADULT; BRAIN NEOPLASMS; CHLORIDE CHANNELS; FEMALE; GAMMA-AMINOBUTYRIC ACID; GLIOMA; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; NEOPLASM STAGING; PROGNOSIS; PROTEIN ISOFORMS; PROTEIN SUBUNITS; RECEPTORS, GABA; RETROSPECTIVE STUDIES; RNA, MESSENGER; SURVIVAL RATE;

EID: 84861215807     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037041     Document Type: Article

References (39)

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, et al. (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114: 97-109.
2. Ohgaki H, Kleihues P, (2005) Epidemiology and etiology of gliomas. Acta Neuropathol 109: 93-108.
3. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, et al. (2005) European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group.Cancer104 and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996.
4. Soffietti R, Baumert BG, Bello L, von Deimling A, Duffau H, et al. (2010) Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task Force. Eur J Neurol 17: 1124-1133.
5. Birnir B, Korpi ER, (2007) The impact of subcellular localization and intracellular neuronal proteins on properties of GABA(A) receptors. Curr Pharm Des 13: 3169-3177.
6. Young SZ, Bordey A, (2009) GABA's control of stem and cancer cell proliferation in adult neuronal and peripheral niches. Physiology (Bethesda) 24: 171-185.
7. Olsen RW, Sieghart W, (2008) International Union of Pharmacology. Subtypes of γ- Aminobutyric Acid A Receptors: Classification on the Basis of Subunit Composition, Pharmacology, and Function. Pharmacol Rev 60: 243-260.
8. Semyanov A, Walker MC, Kullmann DM, (2003) GABA uptake regulates cortical excitability via cell type-specific tonic inhibition. Nat Neurosci 6: 484-490.
9. Farrant M, Nusser Z, (2005) Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors. Nat Rev Neurosci 6: 215-229.
10. Bureau M, Laschet J, Bureau-Heeren M, Hennuy B, Minet A, et al. (1995) Astroglial cells express large amounts of GABAA receptor proteins in mature brain. J Neurochem 65: 2006-2015.
11. Colombo JA, Bentham C, (2006) Immunohistochemical analysis of subcortical white matter astroglia of infant and adult primate brains, with a note on resident neurons. Brain Res 1100: 93-103.
12. Bjurstöm H, Wang J, Ericsson I, Bengtsson M, Liu Y, et al. (2008) GABA, a natural immunomodulator of T lymphocytes. J Neuroimmunol 205: 44-50.
13. Bhat R, Axtell R, Mitra A, Miranda M, Lock C, et al. (2010) Inhibitory role for GABA in autoimmune inflammation. Proc Natl Acad Sci U S A 107: 2580-2585.
14. Aronica E, Redeker S, Boer K, Spliet WG, van Rijen PC, et al. (2007) Inhibitory networks in epilepsy-associated gangliogliomas and in the perilesional epileptic cortex. Epilepsy 74: 33-44.
15. Jussofie A, Reinhardt V, Kalff R, (1994) GABA binding sites: their density, their affinity to muscimol and their behaviour against neuroactive steroids in human gliomas of different degrees of malignancy. J Neural Transm Gen Sect 96: 233-241.
16. Labrakakis C, Patt S, Hartmann J, Kettenmann H, (1998) Functional GABA(A) receptors on human glioma cells. Eur J Neurosci 10: 231-238.
17. Synowitz M, Ahmann P, Matyash M, Kuhn SA, Hofmann B, et al. (2001) GABA(A)-receptor expression in glioma cells is triggered by contact with neuronal cells. Eur J Neurosci 14: 1294-1302.
18. Pignatti F, van den Bent M, Curran D, Debruyne C, Sylvester R, et al. (2002) Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 20: 2076-2084.
19. Von Deimling A, Korshunov A, Hartmann C, (2011) The next generation of glioma biomarkers: MGMT methylation, BRAF fusions and IDH1 mutations. Brain Pathol 21: 74-87.
20. Schwirtlich M, Emri Z, Antal K, Mátè Z, Katarova Z, Szabo G, (2010) GABA(A) and GABA(B) receptors of distinct properties affect oppositely the proliferation of mouse embryonic stem cells through synergistic elevation of intracellular Ca(2+). FASEB J 24: 1218-1228.
21. Uusi-Oukari M, Korpi ER, (2010) Regulation of GABAA Receptor Subunit Expression by Pharmacological Agents. Pharmacol Rev 62: 97-135.
22. Capogna M, Pearce RA, (2010) GABAA,slow: causes and consequences. Trends in Neuroscience 34: 101-112.
23. Belelli D, Harrison NL, Maguire J, Macdonald RL, Walker MC, et al. (2009) Extrasynaptic GABAA receptors: form, pharmacology, and function. J Neurosci 14: 12757-12763.
24. Rosas-Arellano A, Parodi J, Machuca-Parra AI, Sánchez-Gutiérrez A, Inestrosa NC, et al. (2011) The GABA(A)ρ receptors in hippocampal spontaneous activity and their distribution in hippocampus, amygdala and visual cortex. Neurosci Lett 500: 20-25.
25. Feigenspan A, Wässle H, Bormann J, (1993) Pharmacology of GABA receptor Cl- channels in rat retinal bipolar cells. Nature 361: 159-162.
26. Pan Y, Ripps H, Qian H, (2006) Random assembly of GABA rho1 and rho2 subunits in the formation of heteromeric GABA(C) receptors. Cell Mol Neurobiol 26: 289-305.
27. Martínez-Delgado G, Estrada-Mondragón A, Miledi R, Martínez-Torres A, (2010) An update on GABAr Receptors. Curr Neuropharmacol 8: 422-433.
28. Bormann J, Feigenspan A, (1995) GABAC receptors. Trends Neurosci 18: 515-519.
29. Enz R, Cutting GR, (1999) GABAC receptor rho subunits are heterogeneously expressed in the human CNS and form homo- and heterooligomers with distinct physical properties. Eur J Neurosci 11: 41-50.
30. Shaw EG, Daumas-Duport C, Scheithauer BW, Gilbertson DT, O'Fallon JR, et al. (1989) Radiation therapy in the management of low-grade supratentorial astrocytomas. J Neurosurg 70: 853-861.
31. Okamoto Y, Di Patre PL, Burkhard C, Horstmann S, Jourde B, et al. (2004) Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas. Acta Neuropathol 108: 49-56.
32. Yang HJ, Kim JE, Paek SH, Chi JG, Jung HW, Kim DG, (2003) The significance of gemistocytes in astrocytoma. Acta Neurochir (Wien) 145: 1097-1103.
33. Angulo MC, Le Meur K, Kozlov AS, Charpak S, Audinat E, (2008) GABA, a forgotten gliotransmitter. Prog Neurobiol 86: 297-303.
34. Schmittgen TD, Livak KJ, (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108.
35. Qu M, Aronica E, Boer K, Fällmar D, Kumlien E, et al. (2009) DLG3/SAP102 protein expression in malformations of cortical development: a study of human epileptic cortex by tissue microarray. Epilepsy Res 84: 33-41.
36. Elsir T, Qu M, Berntsson SG, Orrego A, Olofsson T, et al. (2011) PROX1 is a predictor of survival for gliomas WHO grade II. Br J Cancer104: 1747-1754.
37. Uhlén M, Pontén F, (2005) Antibody-based proteomics for human tissue profiling. Mol Cell Proteomics 4: 384-393.
38. Capper D, Zentgraf H, Balss J, Hartmann C, von Deimling A, (2009) Monoclonal antibody specific for IDH1 R132H mutation. Acta Neuropathol 118: 599-601.
39. Paavilainen L, Wernérus H, Nilsson P, Uhlén M, Hober S, et al. (2008) Evaluation of monospecific antibodies: a comparison study with commercial analogs using immunohistochemistry on tissue microarrays. Immunohistochem Mol Morphol 16: 493-502.